Yu Wang

Fei Wang, Kun Li, Yiqi Nie et al.

In this paper, we present our solution to the Cross-View Isolated Sign Language Recognition (CV-ISLR) challenge held at WWW 2025. CV-ISLR addresses a critical issue in traditional Isolated Sign Language Recognition (ISLR), where existing datasets predominantly capture sign language videos from a frontal perspective, while real-world camera angles often vary. To accurately recognize sign language from different viewpoints, models must be capable of understanding gestures from multiple angles, making cross-view recognition challenging. To address this, we explore the advantages of ensemble learning, which enhances model robustness and generalization across diverse views. Our approach, built on a multi-dimensional Video Swin Transformer model, leverages this ensemble strategy to achieve competitive performance. Finally, our solution ranked 3rd in both the RGB-based ISLR and RGB-D-based ISLR tracks, demonstrating the effectiveness in handling the challenges of cross-view recognition. The code is available at: https://github.com/Jiafei127/CV_ISLR_WWW2025.

Runchen Wang, Junlin Guo, Siqi Lu et al.

Accurate cell nuclei segmentation is critical for downstream tasks in kidney pathology and remains a major challenge due to the morphological diversity and imaging variability of renal tissues. While our prior work has evaluated early-generation AI cell foundation models in this domain, the effectiveness of recent cell foundation models remains unclear. In this study, we benchmark advanced AI cell foundation models (2025), including CellViT++ variants and Cellpose-SAM, against three widely used cell foundation models developed prior to 2024, using a diverse large-scale set of kidney image patches within a human-in-the-loop rating framework. We further performed fusion-based ensemble evaluation and model agreement analysis to assess the segmentation capabilities of the different models. Our results show that CellViT++ [Virchow] yields the highest standalone performance with 40.3% of predictions rated as "Good" on a curated set of 2,091 challenging samples, outperforming all prior models. In addition, our fused model achieves 62.2% "Good" predictions and only 0.4% "Bad", substantially reducing segmentation errors. Notably, the fusion model (2025) successfully resolved the majority of challenging cases that remained unaddressed in our previous study. These findings demonstrate the potential of AI cell foundation model development in renal pathology and provide a curated dataset of challenging samples to support future kidney-specific model refinement.